Regional Oncology Nursing Council of Southeastern Ontario (RONC-SEO)

 

Intraperitoneal Access Devices

Epidural and Intrathecal

Epidural and intrathecal catheters are temporarily or permanently placed percutaneously into the epidural space, through the second and third lumbar interspace. The epidural space is a potential space between the dura mater memberane covering the spinal cord and the ligamentum flavum and periosteum of the vertebral column. It extends from the foramen magnum to the sacral hiatus. For intrathecal administration, the catheter is advanced below the dura where cerbral spinal fluid circulates. These devices are used for the : administration of chemotherapy intrathecally (route of delivery is in the subarachnoid space : administration of opoid analgesics and anesthetic medications for chronic intractable pain; : administration of opoid analgesics and anesthetic medications foracute pain that is inadequately controlled. (ONS Access Device Guidelines, 2004)

Intraventicular

An intarventricular access device is a dome-shaped , self-sealing reservoir attached to a catheter. The reservoir is implanted underneath the skin and the catheter is inserted into the cranium to the ventricle to provide access to cerebrospinal fluid. The reservoir volume is usually 1.5-2.5 ml. (ONS Access Device Guidelines, 2004) These devices provide access for the administration of multiple therapies e.g. chemotherapy, antibiotics, antifungal and analgesics.They are also used to access cerebrospinal fluid (CSF) for the measure of measurement of intracranial pressure and sampling of CSF. (ONS Access Device Guidelines, 2004)

Intraperitoneal

Intraperitoneal access devices are temporarily or permanently implanted into the peritoneal cavity for access to the peritoneum (Smith & Jason). Intraperitoneal catheters include: intravenous cathlons, pigtail catheters, tenckhoff catheters and implanted ports. Aseptic technique is required to prevent catheter related infections and peritonitis (Lee, Lau & Yeong, 2000). Theses devices allow for the administration of intraperitoneal therapies (including chemotherapy and biotherapy), dialysis, palliation of malignant ascites, and diagnostic testing. (ONS Access Device Guidelines, 2004). In the adult palliative patient with malignant ascites, draining peritoneal fluid can provide temporary symptomatic relief of abdominal pressure, nausea, vomiting, pain, dyspnea or orthopnea (Smith & Jayson, 2003).